Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michele Morari

Showing results (1-10 of 93) with videos related to

Pageof 10
Sort By:
The Analyst|January 14, 2015
Loss of the preferential control over the striato-nigral direct pathway by striatal NMDA receptors in a rat model of Parkinson's diseaseMichele Morari, Martina Fantin
Neuronal Signaling|August 21, 2023
Modeling Parkinson's disease in LRRK2 rodentsChiara Domenicale, Stefano Magnabosco, Michele Morari
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 25, 2011
Progressive motor cortex functional reorganization following 6-hydroxydopamine lesioning in ratsRiccardo Viaro, Michele Morari, Gianfranco Franchi
Journal of Neurochemistry|November 19, 2008
The novel nociceptin/orphanin FQ receptor antagonist Trap-101 alleviates experimental parkinsonism through inhibition of the nigro-thalamic pathway: positive interaction with L-DOPAMatteo Marti, Claudio Trapella, Michele Morari
Journal of Neurochemistry|July 12, 2011
Amantadine attenuates levodopa-induced dyskinesia in mice and rats preventing the accompanying rise in nigral GABA levelsSimone Bido, Matteo Marti, Michele Morari
Experimental Neurology|February 4, 2010
Dual motor response to l-dopa and nociceptin/orphanin FQ receptor antagonists in 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) treated mice: Paradoxical inhibition is relieved by D(2)/D(3) receptor blockadeRiccardo Viaro, Matteo Marti, Michele Morari
Frontiers in Neuroscience|January 11, 2020
Autophagy and LRRK2 in the Aging BrainFederica Albanese, Salvatore Novello, Michele Morari
Journal of Neurochemistry|April 26, 2008
Differential effect of NR2A and NR2B subunit selective NMDA receptor antagonists on striato-pallidal neurons: relationship to motor response in the 6-hydroxydopamine model of parkinsonismMartina Fantin, Yves P Auberson, Michele Morari
Neurobiology of Disease|August 18, 2020
Striatal and nigral muscarinic type 1 and type 4 receptors modulate levodopa-induced dyskinesia and striato-nigral pathway activation in 6-hydroxydopamine hemilesioned ratsAlberto Brugnoli, Clarissa Anna Pisanò, Michele Morari
Neurobiology of Disease|November 3, 2015
Genetic deletion of Rhes or pharmacological blockade of mTORC1 prevent striato-nigral neurons activation in levodopa-induced dyskinesiaAlberto Brugnoli, Francesco Napolitano, Alessandro Usiello, et al.
Pageof 10

Showing results (1-10 of 93) with videos related to

Sort By:
Pageof 10
The Analyst|January 14, 2015
Loss of the preferential control over the striato-nigral direct pathway by striatal NMDA receptors in a rat model of Parkinson's diseaseMichele Morari, Martina Fantin
Neuronal Signaling|August 21, 2023
Modeling Parkinson's disease in LRRK2 rodentsChiara Domenicale, Stefano Magnabosco, Michele Morari
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 25, 2011
Progressive motor cortex functional reorganization following 6-hydroxydopamine lesioning in ratsRiccardo Viaro, Michele Morari, Gianfranco Franchi
Journal of Neurochemistry|November 19, 2008
The novel nociceptin/orphanin FQ receptor antagonist Trap-101 alleviates experimental parkinsonism through inhibition of the nigro-thalamic pathway: positive interaction with L-DOPAMatteo Marti, Claudio Trapella, Michele Morari
Journal of Neurochemistry|July 12, 2011
Amantadine attenuates levodopa-induced dyskinesia in mice and rats preventing the accompanying rise in nigral GABA levelsSimone Bido, Matteo Marti, Michele Morari
Experimental Neurology|February 4, 2010
Dual motor response to l-dopa and nociceptin/orphanin FQ receptor antagonists in 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) treated mice: Paradoxical inhibition is relieved by D(2)/D(3) receptor blockadeRiccardo Viaro, Matteo Marti, Michele Morari
Frontiers in Neuroscience|January 11, 2020
Autophagy and LRRK2 in the Aging BrainFederica Albanese, Salvatore Novello, Michele Morari
Journal of Neurochemistry|April 26, 2008
Differential effect of NR2A and NR2B subunit selective NMDA receptor antagonists on striato-pallidal neurons: relationship to motor response in the 6-hydroxydopamine model of parkinsonismMartina Fantin, Yves P Auberson, Michele Morari
Neurobiology of Disease|August 18, 2020
Striatal and nigral muscarinic type 1 and type 4 receptors modulate levodopa-induced dyskinesia and striato-nigral pathway activation in 6-hydroxydopamine hemilesioned ratsAlberto Brugnoli, Clarissa Anna Pisanò, Michele Morari
Neurobiology of Disease|November 3, 2015
Genetic deletion of Rhes or pharmacological blockade of mTORC1 prevent striato-nigral neurons activation in levodopa-induced dyskinesiaAlberto Brugnoli, Francesco Napolitano, Alessandro Usiello, et al.
Pageof 10